Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ACTRN12626000500358) titled 'Sex specific differences in outcomes following atrial fibrillation (AF) ablation versus medical therapy in patients with AF and heart failure' on April 22.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Alfred Hospital
Condition:
atrial fibrillation
heart failure
atrial fibrillation
heart failure
Cardiovascular - Other cardiovascular diseases
Intervention:
All participants will undergo a 5-week period of medical optimisation as part of standard care. The 5 ...